Funding for this research was provided by:
Janssen Pharmaceuticals (n/a)
Received: 4 March 2019
Accepted: 11 August 2019
First Online: 27 August 2019
Ethics approval and consent to participate
: We applied to and received approval from the Human Subjects Research Committee of Hennepin County Medical Center/Hennepin Healthcare System, Inc. The Truven MarketScan data used for this project were procured via a Services and License Agreement between IBM Corporation and Hennepin Healthcare Research Institute, CDRG’s parent research organization.
: Not applicable.
: JBW is on the Speakers’ Bureau for OPKO Renal. TGNT is employed by Precision Health Economics. MKH, CN, and RR are employed by Janssen. DTG has provided statistical consultation to DaVita Clinical Research. SL, YP, and JL report no conflicts of interest.